1. Pink Sheet

CSL Behring: EU Could Support Gene Therapy Access By Sharing Contracting ‘Best Practices’

 
• By Eliza Slawther

While CSL Behring has successfully negotiated reimbursement contracts for its one-time gene therapy Hemgenix in several European countries, it says there are still “barriers to innovative contracting solutions” in some member states that need to be addressed.

Innovative thinking can help make gene therapy access a reality, says CSL Behring (Shutterstock)
Key Takeaways
  • CSL Behring says the European Commission could help improve access to cell and gene therapies in member states by sharing best practices around access mechanisms.

The European Commission could “play a role in sharing best practices” in relation to using innovative contracting solutions “to facilitate...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cell & Gene Therapies

More from Market Access